title: Evidence for cellular injury in the midbrain of rats following chronic constriction injury of the sciatic nerve.
abstract: Complex behavioural disabilities, as well as pain, characterise neuropathic pain conditions for which clinical treatment is sought. In rats, chronic constriction injury (CCI) of the sciatic nerve evokes, allodynia and hyperalgesia as well as three distinct patterns of disability, characterised by changes in social and sleep-wake behaviours: (i) Pain & Disability; (ii) Pain & Transient Disability and (iii) Pain alone. Importantly, the degree of allodynia and hyperalgesia is identical for each of these groups. Social-interactions and sleep-wake behaviours are regulated by neural networks, which converge on the periaqueductal grey (PAG). Rats with Pain & Disability show astrocyte activation restricted to the lateral and ventrolateral PAG. Reactive astrocytes are a hallmark of cell death (apoptosis and necrosis). Quantitative real-time RT-PCR for the mRNAs encoding Bax, Bcl-2, heat shock protein 60 (HSP60), mitogen activated kinase kinase (MEK2) and iNOS was performed on the dorsal midbrains of individual, disability characterised rats, extending our earlier Gene-Chip data, showing a select up-regulation of Bax and MEK2 mRNA, and a down-regulation of HSP60 mRNA, in Pain & Disability rats. The anatomical location of TUNEL and cleaved-caspase-3 immunoreactive profiles in the midbrain was also identified. Rats with Pain & Disability showed: (i) pro-apoptotic ratios of Bax:Bcl-2 mRNAs; (ii) decreased HSP60 mRNA; (iii) increased iNOS and MEK2 mRNAs; (iv) TUNEL-positive profiles in the lateral and ventrolateral PAG; and (v) caspase-3 immunoreactive neurons in the mesencephalic nucleus of the trigeminal nerve. Cell death in these specific midbrain regions may underlie the disabilities characterising this subgroup of nerve-injured rats.
authors.affiliation: School of Medical Sciences (Anatomy and Histology), The University of Sydney, NSW 2006, Australia.
authors.forename: David
authors.initials: D
authors.lastname: Mor
authors.forename: Alison L
authors.initials: AL
authors.lastname: Bembrick
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Austin
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Keay
mesh_terms: D000818:Animals; D017209:Apoptosis; D053148:Caspase 3 / Q000032:analysis / Q000378:metabolism; D018834:Chaperonin 60 / Q000032:analysis / Q000378:metabolism; D003251:Constriction, Pathologic / Q000150:complications / Q000473:pathology; D004195:Disease Models, Animal; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D005911:Gliosis / Q000503:physiopathology; D006801:Humans; D006930:Hyperalgesia / Q000378:metabolism / Q000503:physiopathology*; D007150:Immunohistochemistry; D048370:MAP Kinase Kinase 2 / Q000032:analysis / Q000378:metabolism; D008297:Male; D008636:Mesencephalon / Q000378:metabolism*; D019964:Mood Disorders / Q000209:etiology / Q000503:physiopathology; D009457:Neuroglia / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000032:analysis / Q000378:metabolism; D010487:Periaqueductal Gray / Q000378:metabolism / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000503:physiopathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012584:Sciatic Nerve / Q000378:metabolism*; D020426:Sciatic Neuropathy / Q000209:etiology / Q000503:physiopathology*; D012893:Sleep Wake Disorders / Q000209:etiology / Q000503:physiopathology; D014278:Trigeminal Nuclei / Q000378:metabolism; D014746:Vimentin / Q000032:analysis / Q000378:metabolism; D051028:bcl-2-Associated X Protein / Q000032:analysis / Q000378:metabolism
chemical_list: D018834:Chaperonin 60; D005904:Glial Fibrillary Acidic Protein; D014746:Vimentin; D051028:bcl-2-Associated X Protein; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; D048370:MAP Kinase Kinase 2; D053148:Caspase 3